Pharmafile Logo
Pharmafocus logo
Advanced Search

Roche

Showing 15 posts of 710 posts found.

Roche unveils strong combination treatment data in lung cancer

November 20, 2017
Research and Development, Sales and Marketing Cancer, NSCLC< lung cancer, Roche, avastin, immunotherapy, pharma, tecentriq

Roche has unveiled new Phase 3 efficacy data which showed strong findings for its immunotherapy Tecentriq (atezolizumab) in combination with …

News
samsung_bioepis

Samsung Bioepis’ Ontruzant becomes first Herceptin biosimilar approved in Europe

November 20, 2017
Sales and Marketing EMA, Herceptin, Roche, Samsung Bioepis

Samsung Bioepis has announced that Ontruzant, the company’s biosimilar version of Roche’s Herceptin, has been awarded marketing authorisation in Europe …

News

Roche’s haemophillia A treatment gets nod but with black box warning

November 17, 2017
Medical Communications, Sales and Marketing Hemlibra, Roche, biotech, drugs, pharma, pharmaceutical

Roche needs its pipeline to pick up quick successes, with its big earners are looking at precipitous patent cliffs, and, …

News
arvinas-0004168-2

Genentech cements relationship with Arvinas with $650m deal

November 16, 2017
Research and Development, Sales and Marketing Arvinas, Genentech, Roche, biotech, drugs, pharma, pharmaceutical

Genentech first signed a deal with Arvinas, a biotech focused on drugs within the protein degradation class, back in 2015. …

News
roche_dark_0

EMA recommends approval of Roche’s Ocrevus in relapsing forms of multiple sclerosis

November 13, 2017
Sales and Marketing MS, Ocrevus, Roche, multiple sclerosis, pharma

Roche has revealed that its humanised monoclonal antibody Ocrevus (ocrelizumab) received a positive recommendation from the Committee for Medical Products …

News
nhs_sign

NHS England seals access deals with big pharma for breast cancer and MS

November 9, 2017
Sales and Marketing Cancer, Mavenclad, Merck, NHS, NHS England, NICE, Perjeta, Roche, Simon Stevens, breast cancer, multiple sclerosis

NHS England has entered into a commercial agreement with Merck which aims to provide access to innovative treatments for both …

News
roche_dark_0

FDA expands Roche drug indication to approve first-ever treatment for rare blood cancer

November 7, 2017
Manufacturing and Production, Sales and Marketing Cancer, Erdheim-Chester Disease, FDA, Roche, blood cancer, pharma

The FDA has announced the approval of Roche’s Zelboraf (vemurafenib) in the treatment of Erdheim-Chester Disease (ECD), expanding its already …

News
roche

Roche’s Tecentriq approved for funding in UK in bladder cancer

November 1, 2017
Research and Development, Sales and Marketing Roche, biotech, drugs, pharma, pharmaceutical

In a rare spot of good news for Tecentriq (atezolizumab), after a turbulent period, Roche’s drug has been given the …

News
shutterstock_138095450

AZ tops annual R&D spend in UK, Roche is greatest pharma spender worldwide

October 24, 2017
Manufacturing and Production, Research and Development, Sales and Marketing AstraZeneca, GSK, GlaxoSmithKline, R&D, Roche, pwC

New findings of a report by PwC have revealed the biggest spenders in R&D worldwide as global spending hits $700 …

News
roche__tree

Roche launches Warp Drive antibiotic collaboration for $387m

October 16, 2017
Sales and Marketing Antibiotics, Roche, biotech, drugs, pharma, pharmaceutical

Roche had tentatively begun to re-enter the antibiotic space, but it has now signalled its growing intention to move in …

News

NICE gives final draft guidance on two key cancer drugs

October 12, 2017
Sales and Marketing Bayer, CDF, Cancer, Cancer Drugs Fund, Erivedge, NICE, Roche, Stivarga

NICE has announced it has published its final draft guidance for two cancer treatments, covering Bayer’s Stivarga (regorafenib) in the …

News
roche_close

Roche’s 99% accurate Zika test receives FDA approval

October 9, 2017
Sales and Marketing Roche, Zika, biotech, drugs, pharma, pharmaceutical

Roche has revealed that the FDA has given approval to its cobas Zika test to determine whether a blood sample …

News
aspen

South Africa’s over-charging case against Aspen dissolves, remains against big names

October 6, 2017
Medical Communications, Sales and Marketing Genentech, Pfizer, Roche, aspen, biotech, drugs, pharma, pharmaceutical

South Africa’s Competition Commission has admitted that there is no case to be heard against Aspen and Equity, in regards …

News
rocherooflr

FDA awards Roche priority review in HER2-positive breast cancer

October 2, 2017
Sales and Marketing Cancer, FDA, Herceptin, Perjeta, Roche, breast cancer, pharma, pharmaceutical

Roche has revealed that its monoclonal antibody Perjeta (pertuzumab) has been awarded priority review by the FDA as an adjuvant …

News
roche

Roche chalks up Swiss approval for multiple sclerosis drug Ocrevus

September 28, 2017
Sales and Marketing Ocrevus, Roche, multiple sclerosis, pharma, pharmaceutical

Roche has announced that its drug Ocrevus (ocrelizumab) has received marketing approval in Switzerland for the treatment of active relapsing …

News
The Gateway to Local Adoption Series

Latest content

Teva announces positive results from trial of AJOVY for migraine

December 5, 2025

Vetter announces leadership transition as Thomas Otto retires

December 5, 2025

Samsung Bioepis announces launch of two new denosumab biosimilars in Europe

December 4, 2025

Medicus Pharma appoints Carolyn Bonner as CFO

December 4, 2025

Sandoz launches two new bone disease biosimilars in Europe

December 3, 2025